Lions Eye Institute

Running trials

• Recruiting

  A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

  NCT06628947· Phase 2· Kiora Pharmaceuticals, Inc.· Source

• Recruiting

  Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

  NCT06825702· Phase 2· Kiora Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT06795048· Phase 4· Hoffmann-La Roche· Source

• Active, not recruiting

  Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

  NCT05610319· Phase 4· McMaster University· Source

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Hoffmann-La Roche· Source

• Active, not recruiting

  Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

  NCT05573984· PYC Therapeutics· Source

• Active, not recruiting

  An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

  NCT05300724· Genentech, Inc.· Source

• Active, not recruiting

  A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

  NCT04657289· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Retinitis pigmentosa1 recruiting

Closed trials

• Completed

  Vamikibart in Participants With Uveitic Macular Edema

  NCT05642325· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT04740671· Phase 3· Shanghai Henlius Biotech· Source

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Hoffmann-La Roche· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source

• Completed

  Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy

  NCT04576689· Phase 2· Ripple Therapeutics Pty Ltd· Source

• Completed

  Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome

  NCT04355689· Phase 1/2· Nacuity Pharmaceuticals, Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Glaucoma19 works · 0 trials
• Retinitis pigmentosa4 works · 3 trials